Warner Chilcott plc (WCRX)
-NasdaqGS 19.60 
0.39(2.03%) May 20, 4:00PM EDT|After Hours
:
19.63 0.03 (0.13%) May 20, 6:20PM EDT
| Prev Close: | 19.21 |
|---|
| Open: | 19.27 |
|---|
| Bid: | 18.52 x 500 |
|---|
| Ask: | 19.75 x 500 |
|---|
| 1y Target Est: | 20.03 |
|---|
| Beta: | 1.37 |
|---|
| Next Earnings Date: | 31-Jul-13 |
|---|
| Day's Range: | 19.10 - 20.30 |
|---|
| 52wk Range: | 10.85 - 20.51 |
|---|
| Volume: | 59,892,561 |
|---|
| Avg Vol (3m): | 5,970,860 |
|---|
| Market Cap: | 4.92B |
|---|
| P/E (ttm): | 12.17 |
|---|
| EPS (ttm): | 1.61 |
|---|
| Div & Yield: | 0.50 (2.60%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Kasowitz Benson, Eversheds, Latham, Davis:Business of Lawat Bloomberg(Tue 12:01AM EDT)
- Actavis Lowers Tax Rate to 17% After Warner Chilcott Dealat Bloomberg(Tue 12:01AM EDT)
- Final Trade: Your First Move for Tuesday, May 21at CNBC(Mon, May 20)
- Actavis buying Warner Chilcott in $8.5B dealAP(Mon, May 20)
- Everyone Wins From This Acquisitionat Motley Fool(Mon, May 20)
- [video] Fast Money Final Tradeat CNBC(Mon, May 20)
- Wall Street ends flat on correction worriesReuters(Mon, May 20)
- [$$] Actavis Charts New Course With Warner Dealat The Wall Street Journal(Mon, May 20)
- Stocks Slip on Concerns Markets Are Overpricedat TheStreet(Mon, May 20)
- Stocks End Lower; Dow, S&P Briefly Hit New Highsat CNBC(Mon, May 20)
- On The Fly: Closing Wrapat theflyonthewall.com(Mon, May 20)
- Merger Monday on Wall Streetat CNNMoney.com(Mon, May 20)
- Despite Large Gains, This Stock Is Still a Buyat Motley Fool(Mon, May 20)
- Daily Wrap: May 20, 2013at Forbes(Mon, May 20)
- [$$] Actavis to Buy Warner Chilcottat The Wall Street Journal(Mon, May 20)
Key Statistics
| Forward P/E (1 yr): | 6.22 |
|---|
| P/S (ttm): | 1.97 |
|---|
| Ex-Dividend Date: | 29-May-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.34 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.84 |
|---|
| Mean Recommendation*: | 1.9 |
|---|
| PEG Ratio (5 yr expected): | -56.60 |
|---|
Business Summary
Warner Chilcott Public Limited Company, a specialty pharmaceutical company, engages in the development, manufacture, promotion, and franchise of branded pharmaceutical products focusing on the womens healthcare, gastroenterology, urology, an...
View More